Cargando…
The supernatant of cervical carcinoma cells lines induces a decrease in phosphorylation of STAT-1 and NF-κB transcription factors associated with changes in profiles of cytokines and growth factors in macrophages derived from U937 cells
Macrophages are presents in the tumor microenvironment and acquire different phenotypic and functional characteristics in response to microenvironmental signals. Macrophages can be differentiated into two phenotypes: M1 or pro-inflammatory (classically activated), and M2 or anti-inflammatory macroph...
Autores principales: | Sánchez-Reyes, Karina, Pedraza-Brindis, Eliza J, Hernández-Flores, Georgina, Bravo-Cuellar, Alejandro, López-López, Brenda A, Rosas-González, Vida C, Ortiz-Lazareno, Pablo C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103616/ https://www.ncbi.nlm.nih.gov/pubmed/31099286 http://dx.doi.org/10.1177/1753425919848841 |
Ejemplares similares
-
Cervical Cancer Cell Supernatants Induce a Phenotypic Switch from U937-Derived Macrophage-Activated M1 State into M2-Like Suppressor Phenotype with Change in Toll-Like Receptor Profile
por: Sánchez-Reyes, Karina, et al.
Publicado: (2014) -
Pentoxifylline and the proteasome inhibitor MG132 induce apoptosis in human leukemia U937 cells through a decrease in the expression of Bcl-2 and Bcl-XL and phosphorylation of p65
por: Bravo-Cuellar, Alejandro, et al.
Publicado: (2013) -
Combination Blockade of the IL6R/STAT-3 Axis with TIGIT and Its Impact on the Functional Activity of NK Cells against Prostate Cancer Cells
por: González-Ochoa, S., et al.
Publicado: (2022) -
Sensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss
por: Ortiz-Lazareno, Pablo César, et al.
Publicado: (2014) -
Dual STAT-3 and IL-6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL-6/IL-6R/STAT-3 axis
por: Méndez-Clemente, Anibal, et al.
Publicado: (2022)